HDV vs IBB
iShares Core High Dividend ETF vs iShares Biotechnology ETF
- • HDV has the lower expense ratio at 0.08% vs 0.44% for IBB.
- • HDV pays a higher dividend yield (2.90%).
Side-by-side metrics
| Metric | HDV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.90% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $13.66B | $9.09B |
YTD return | 16.00% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.32 | 0.69 |
P/E ratio | 21.95 | 24.79 |
Last price | $27.62 | $196.62 |
Inception | — | — |
Issuer | iShares | iShares |
HDV top holdings
| XOM | Exxon Mobil Corp | 7.26% |
| ABBV | AbbVie Inc | 6.48% |
| CVX | Chevron Corp | 5.41% |
| VZ | Verizon Communications Inc | 5.23% |
| HD | The Home Depot Inc | 4.96% |
| PG | Procter & Gamble Co | 4.81% |
| PM | Philip Morris International Inc | 4.42% |
| PFE | Pfizer Inc | 4.31% |
| MRK | Merck & Co Inc | 4.12% |
| KO | Coca-Cola Co | 3.98% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About HDV
HDV (iShares Core High Dividend ETF) is US high-dividend stocks with quality screen. Managed by iShares, the fund carries $13.7B in assets under management, an expense ratio of 0.08%, a dividend yield of 2.90%. Its largest holding is Exxon Mobil Corp (XOM), which represents 7.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.3%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.